Sarabhai Chemicals

What Sarabhai Chemicals does

Sarabhai Chemicals is a privately held Indian pharmaceutical manufacturer headquartered in Ahmedabad, Gujarat, operating as Sarabhai Chemicals & Lemantus Pharmaceuticals PVT. LTD. under the Ambalal Sarabhai Enterprises (ASE) conglomerate. The company manufactures a diversified portfolio across three therapeutic categories: veterinary medicines (antibiotics, antiparasitics, anti-inflammatories, wound care products for livestock and pets), oncology drugs (paclitaxel, gemcitabine, oxaliplatin, hydroxyurea, antiemetics), and IVF/fertility medications (FSH, HMG, HCG, progesterone). Its portfolio includes legacy brands such as Xydocin, positioning the company as a pioneer of Penicillin manufacturing in India dating back to the original Sarabhai pharmaceutical operations in the 1950s-70s under Dr. Vikram Sarabhai.

The company's go-to-market is B2B, operating through a direct field force of approximately 50 executives and a distribution network of 108 stockists covering every state and district in India. Products are also available through an inquiry-based e-commerce storefront on sarabhaichemicals.com, with pricing ranging from INR 40 (entry-level veterinary bolus) to INR 15,000 (premium oncology injections like Taxogem 120 mg). There is no subscription or recurring revenue model; sales are one-time unit purchases. Customer segments include veterinary professionals and livestock farmers, oncology treatment centers, fertility/IVF clinics, and authorized distributors. International operations are managed through a wholly-owned US subsidiary, Asence Inc., though current shipping is restricted to India-based customers.

The company is managed by the third-generation Sarabhai family: Mr. Kartikeya V. Sarabhai as Chairman (ASE) and Mr. Mohal K. Sarabhai as Director, who also serves as President, CEO, and Director of Asence USA and Asence Pharma Pvt. Ltd. India. The parent ASE conglomerate historically held over 10% Indian pharmaceutical market share in the 1980s; the current entity is a smaller focused manufacturer with 11-50 employees and historical international partnerships in oncology (USA, Netherlands, Germany, Brazil) that shaped its current portfolio.

Name

Sarabhai Chemicals

Legal name

Sarabhai Chemicals & Lemantus Pharmaceuticals PVT. LTD.

Website

https://sarabhaichemicals.com

Company type

Private

Founded year

1978

Operating status

Operating

Headcount range

11–50 employees

Short description

Sarabhai Chemicals is an Ahmedabad-based Indian pharmaceutical manufacturer producing veterinary medicines, oncology drugs, and IVF/fertility medications. It sells through 108 stockists and a direct field force, serving veterinarians, oncology centers, and fertility clinics across India under the Ambalal Sarabhai Enterprises group.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic & Private-Label Veterinary Pharmaceuticals (HLAMAEAM)

akta.pro secondary industries

Parasiticides & Ectoparasite Control (Flea/Tick/Heartworm) (HLAMAEAD), Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB), Pain Management, Anesthesia & Critical Care Drugs (HLAMAEAF)

Keywords

• Veterinary pharmaceuticals
• Oncology medications
• Fertility medications
• Pharmaceutical manufacturing
• Animal health products

Headquarters

HQ city

Ahmedabad

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Product Sales: Direct sales of pharmaceutical products including veterinary medicines, oncology drugs, and IVF/fertility medications through their e-commerce platform and distributor network. Products are sold as one-time purchases with prices ranging from approximately ₹40 to ₹15,000 per unit.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Sarabhai Chemicals manufactures and sells pharmaceutical products across three main therapeutic areas: veterinary medicines (antibiotics, antiparasitics, anti-inflammatories, wound care, and nutritional supplements for livestock and pets), oncology drugs (paclitaxel, gemcitabine, oxaliplatin, hydroxyurea, and supportive antiemetics), and IVF/fertility medications (follicle stimulating hormones, gonadotropins, and progesterone formulations). The company distributes these products through 108 stockists covering every state and district of India, plus an inquiry-based e-commerce storefront and a field sales force serving veterinary professionals, oncology treatment centers, and fertility clinics.

Product overview

Sarabhai Chemicals is a pharmaceutical manufacturer offering a diversified portfolio of veterinary, IVF (fertility), and oncology products. The product portfolio includes three main categories: Veterinary products (antibiotics, antiparasitics, anti-inflammatories, nutritional supplements, and wound care products for livestock and pets); IVF products (follicle stimulating hormones, gonadotropins, progesterone, and fertility medications); and Oncology products (chemotherapy agents including paclitaxel, gemcitabine, oxaliplatin, hydroxyurea, and antiemetics for cancer treatment support). The company operates as a B2B pharmaceutical supplier with products available across all states of India through a network of stockists and distributors. Key product lines include Normectin (ivermectin-based antiparasitics), Xidoxy (oxytetracycline antibiotics), Xydocin (penicillin-streptomycin combinations), Folisar and Menosar (IVF hormones), Paxtal and Taxogem (oncology drugs), and various nutritional supplements. The company was founded by Dr. Vikram Sarabhai and is part of the Ambalal Sarabhai Enterprises group with a history dating back to 1880.

Differentiator

Problem solved

Functional benefit

Brands

• Xydocin: Pioneer Penicillin brand in India
• Hydrosar

Products and services

• Veterinary Pharmaceuticals Veterinary drugs used for therapeutic and prophylactic purposes in animals to regulate bacterial infections and prevent outbreaks of animal diseases; includes antibiotics, antiparasitics, anti-inflammatories, wound care products, and nutritional supplements for cattle, sheep, goats, pigs, and pets. Sold to veterinarians, animal clinics, livestock farmers, and authorized distributors across India.
• Oncology Pharmaceuticals Therapeutic drugs used to treat cancer, a group of diseases caused by uncontrolled growth and division of abnormal cells. Includes chemotherapy agents (paclitaxel, gemcitabine, oxaliplatin), targeted therapies, hydroxyurea, antiemetics for chemotherapy-induced nausea, and supportive care medications. Sold to hospitals, cancer treatment centers, and oncology departments across India.
• IVF and Fertility Pharmaceuticals Medications used to prepare the body for fertility treatment, increase the probability of healthy egg release from ovaries, and improve chances of establishing and maintaining pregnancy. Includes follicle stimulating hormones (FSH), human menopausal gonadotropin (HMG), human chorionic gonadotropin (HCG), and progesterone-based products. Sold to fertility clinics and reproductive health centers across India.

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Five partnerships are on record, tiered core and minor.

• USA-based Prime Oncology ManufacturercoreStrategic or Co-development Partner · 1 January 1999In 1999-2000, the company came into an MoU for retailing of Oncology products of a prime manufacturer from USA, further strengthening their oncology division.
• USA Pharmaceutical Manufacturers (Proleukin IL2 and Cardioxane)coreStrategic or Co-development Partner · 1 January 1997In 1997, Sarabhai Chemicals collaborated with Premium pharma manufacturers in USA for two biotech testing products - Proleukin (IL2) for MRCC and Cardioxane (Dexrazoxane) for chemotherapy induced cardio toxicity. This partnership helped introduce advanced oncology treatments in India.
• Brazilian Pharmaceutical ManufacturerminorStrategic or Co-development PartnerThe company engaged in scientific participation with a major pharmaceutical manufacturer in Brazil to manufacture decontaminated insulin injections, demonstrating international scientific collaboration.
• German Pharmaceutical Brands (CONTRAMAL)coreStrategic or Co-development PartnerCONTRAMAL, an oral formulation was manufactured and introduced for the first time in the country in collaboration with leading German pharmaceutical brands. The group is the foremost with marketing rights for this product.
• Asence Pharma Private Limited / Asence Inc. USAcoreOEM/ Whitelabel/ Licensing PartnerInternationally, Sarabhai Chemicals is identified by Asence Pharma Private Limited, a subsidiary company of Asence Inc. USA. Mr. Mohal K. Sarabhai is President, CEO and Director of both Asence USA and Asence Pharma Pvt. Ltd. India. This subsidiary handles international operations and business network expansion.

Scale indicators7 records

Recent moves8 records

Expansion highlights4 records

Broad incumbents

• Zoetis: World's largest animal health company, spun off from Pfizer, offering medicines, vaccines, and diagnostics across livestock and companion animals. Comparable as a broad incumbent and benchmark for veterinary pharmaceutical product and distribution scale.
• Cipla: Major Indian pharmaceutical company with broad oncology portfolio including paclitaxel, gemcitabine, and other chemotherapy agents. Comparable as a domestic competitor in the oncology injectable segment where Sarabhai's 19 oncology SKUs compete.
• Intas Pharmaceuticals: Large Indian pharmaceutical company with a dedicated animal health division (Intas Animal Health). Comparable as a domestic player with overlapping veterinary therapeutics, parasiticides, and biologic products.
• Elanco Animal Health: Global pure-play animal health company with broad portfolio in parasiticides, vaccines, and therapeutic pharmaceuticals. Comparable as a leading industry incumbent in the same veterinary pharma category where Sarabhai competes.
• MSD Animal Health India: Indian operations of Merck Animal Health, one of the largest global animal health companies. Comparable as a broad incumbent in the Indian veterinary pharmaceutical market with extensive parasiticides, vaccines, and therapeutics portfolio.

Direct peers

• Indian Immunologicals: Leading Indian veterinary vaccine and biological products company, subsidiary of the National Dairy Development Board. Comparable as a major Indian animal health player with overlapping veterinary pharmaceutical portfolio.
• Hester Biosciences: Indian veterinary pharmaceutical and biological products manufacturer (vaccines and therapeutics for poultry, livestock, and companion animals). Direct comparable as a domestic Indian vet-pharma specialist with similar product breadth and distribution model.
• Virbac Animal Health India: Indian arm of global veterinary pharma company Virbac. Directly comparable as a veterinary-focused pharmaceutical manufacturer with therapeutic and parasiticidal product lines for livestock and companion animals.

Emerging players

• Bharat Serums and Vaccines (BSV): Indian biopharmaceutical company specializing in equine antitoxins, fertility hormones (FSH, HCG, HMG), and critical care products. Comparable as a domestic specialty peer in the IVF/fertility product line that Sarabhai also markets.
• Vetoquinol: French independent veterinary pharmaceutical company focused on livestock and companion animal therapeutics. Comparable as a mid-sized specialty vet pharma player with similar product mix in antibiotics, anti-inflammatories, and reproductive health.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/sarabhaivet
• LinkedInlinkedin.com/company/sarabhai-chemicals

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sarabhai Chemicals